Perspective Therapeutics (CATX) Notes Payables (2023 - 2026)
Perspective Therapeutics (CATX) reported Notes Payables of $56000.0 for Q1 2026, up 5.66% on a YoY basis from $53000.0 in Q1 2025, and little changed sequentially from $56000.0 in Q4 2025.
Perspective Therapeutics (CATX) Notes Payables (2023 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 4 years of Notes Payables data on file, last reported at $56000.0 in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables rose 5.66% year-over-year to $56000.0; the trailing twelve-month figure through Mar 2026 stood at $56000.0 (up 5.66% YoY), and the FY2025 full-year result was $56000.0, up 7.69% from the prior year.
- Notes Payables steadied at $56000.0 in Q1 2026, from $56000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $80000.0 in Q1 2023 to a low of $48000.0 in Q3 2023.
- A 4-year average of $56076.9 and a median of $54000.0 in 2024 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables plunged 37.5% in 2024 and climbed 7.84% in 2025, its largest moves.
- Tracing CATX's Notes Payables over 4 years: stood at $49000.0 in 2023, then climbed by 6.12% to $52000.0 in 2024, then climbed by 7.69% to $56000.0 in 2025, then changed by 0.0% to $56000.0 in 2026.
- Business Quant data shows CATX's Notes Payables at $56000.0 in Q1 2026, $56000.0 in Q4 2025, and $55000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Perspective Therapeutics | 300.97 Mn | 300.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 80,000.00 |